ORPHAGEN PHARMACEUTICALS
ORPHAGEN PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2001-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.orphagen.com
Total Employee:
11+
Status:
Active
Contact:
+1 (858) 481-6191
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Mobile Non Scaleable Content Sitelinks Search Box Yoast WordPress SEO Plugin Google Maps Yoast SEO Premium Yoast Plugins
Similar Organizations
Addrenex Pharmaceuticals
Addrenex Pharmaceuticals develops drugs to regulate the adrenergic system.
Felicitex Therapeutics
Felicitex Therapeutics is a drug discovery company
Current Advisors List
Official Site Inspections
http://www.orphagen.com Semrush global rank: 5.83 M Semrush visits lastest month: 1.43 K
- Host name: apache2-zoo.pdx1-shared-a1-16.dreamhost.com
- IP address: 75.119.205.255
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Orphagen Pharmaceuticals"
Orphagen Pharmaceuticals - Crunchbase Company …
Orphagen Pharmaceuticals is located in San Diego, California, United States. Who are Orphagen Pharmaceuticals 's competitors? Alternatives and possible competitors to Orphagen Pharmaceuticals may include Felicitex Therapeutics …See details»
Orphagen Pharmaceuticals - Scott Thacher
Orphagen Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Orphagen Pharmaceuticals, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Orphagen Pharmaceuticals - LinkedIn
Orphagen Pharmaceuticals Biotechnology San Diego, CA 761 followers Breakthrough therapies for inflammatory disease and oncologySee details»
ORPHAGEN PHARMACEUTICALS - VentureRadar
Orphagen is a pioneer in the screening, discovery and development of ligands that modulate orphan or unexplored members of the nuclear receptor family. We have proprietary leads for …See details»
Orphagen Pharmaceuticals - Products, Competitors, Financials, …
Orphagen Pharmaceuticals is a pharmaceutical company focused on the discovery and development of small molecule therapies for cancer and inflammatory diseases. The company …See details»
Orphagen Pharmaceuticals - PitchBook
Orphagen Pharmaceuticals General Information Description. Developer of small molecule drugs designed to treat certain orphan nuclear receptors. The company's drugs treat psoriasis and …See details»
Orphagen Pharmaceuticals Company Profile - Office Locations
Orphagen Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for precision oncology and autoimmune disease. It is …See details»
Our Science - Orphagen Pharmaceuticals
Orphagen believes strongly in partnerships and collaborations to accelerate our path to discovery, clinical development and commercialization. We have attracted significant partners and …See details»
Orphagen CEO Scott Thacher, Ph.D. + Director of Chemistry Ruo …
Jul 12, 2013 CEO and Director, Orphagen Pharmaceuticals Scott Thacher founded Orphagen in 2001. He has 30 years of experience in life sciences research and pharmaceutical R&D and …See details»
Orphagen Pharmaceuticals Presents Data on Downstream Targets …
Jun 11, 2022 Orphagen CEO, Scott Thacher, Ph.D., said, “This is a satisfying success story for Orphagen’s corporate strategy to find first-in-class small molecules for unexplored nuclear …See details»
Home - Orphagen
Orphagen is specialized in planning and executing strategies to support entry of orphan drugs in Greek & Cypriot markets, in compliance with the local & international ethics and regulations. …See details»
Pipeline - small molecules to several orphan nuclear receptors
Orphagen successfully partnered its first program for ROR-gamma antagonists with a mid-sized pharmaceutical company ahead of all competitors in the field. Funding from its partnerships …See details»
Orphagen Pharmaceuticals Presents Preclinical Efficacy Data at …
Apr 8, 2022 Release Summary. Orphagen Presents Preclinical Efficacy Data at AACR 2022 on OR-449, a First-in-Class SF-1 Inhibitor, for the Treatment of Leydig Cell TumorsSee details»
Orphagen Pharmaceuticals Receives Rare Pediatric Disease
Jan 17, 2023 Orphagen successfully partnered its first program for ROR-gamma antagonists with a mid-size pharmaceutical company ahead of all competitors in the field. Funding from its …See details»
Orphagen Pharmaceuticals Presents Preclinical Efficacy Data at …
SAN DIEGO, April 8, 2022 — Orphagen Pharmaceuticals Inc., a biotech company pioneering the screening, discovery, and development of small molecule ligands that modulate orphan or …See details»
Orphagenix - Crunchbase Company Profile & Funding
OrphageniX is a biotechnology company that utilizes proprietary single stranded oligonucleotides to treat orphan diseases.See details»
News - Orphagen Pharmaceuticals
Oct 15, 2021 Orphagen Pharmaceuticals, a preclinical stage biopharmaceutical company focused on discovering and developing first-in-class therapeutics for cancer and inflammatory …See details»
ORPHAGEN PHARMACEUTICALS TO PRESENT PRECLINICAL DATA …
May 5, 2021 Orphagen Pharmaceuticals, an early-stage biopharmaceutical company focused on developing and commercializing novel therapies for cancer and other serious diseases with …See details»